| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |